NEWS

Happy new year 2024

To all, Happy New Year! As we embark on a new year, it is the season to take new steps with renewed hearts. We

Read More »

Medical Device Network Excellence Awards 2024: Novius

Press Release “Notice of Commencement of Multi-institutional Joint Research on quasi-3D fluoroscopic images using AI Technology”

Published in AP news”World’s First 3D Medical Image Conversion Technology”

https://apnews.com/press-release/ein-presswire-newsmatics/medical-technology-medical-devices-6c65d8c9db8daf77e3dbcfb8df439d12?utm_source=copy&utm_medium=share


N-Vision 3D creates a sense of depth that is almost palpable. The unique curved videoscope enables a
more accurate spatial understanding, which has been difficult with conventional endoscope systems. The
entire image of the observed object emerges as vividly as in an open surgery. Endoscopic and
laparoscopic surgery can be performed more precisely and more rapidly. N-Vision 3D can be particularly
beneficial for doctors and researchers.
N-Vision 3D technology has been confirmed by Japan’s Ministry of Health in Japan as a programmed
medical device and a non-medical device. It is intended for use in the medical field as an AI image
support system, or in the case of this technology, for data display, storage, and transfer processing. In
2021, Novius’ patent-pending “real-time video conversion technology” was certified as part of the
NVIDIA Inception Partner program. Novius is also a certified Intel® Alliance Partner.
Novius technology has been utilized as part of a joint research project between Novius and Japan’s
National Cancer Center. The objective of the project is to improve the accuracy of diagnosis by using AI
technology to convert 2D fluoroscopic images of lesions into 3D in real-time, enabling the recognition of
the front or back of the image and facilitating the guidance of the bronchoscope to the lesion. The end
goal is to enable patients to undergo surgery sooner. In 2023, Novius was selected as one of 10
Finalists for the 31st General Assembly of the Japanese Association of Medical Sciences
exposition.
Novius’ proprietary AI-based technology has the potential to be transformative not only in the
medical field but also in entertainment, smartphones, security, drones, geophysics, and several other
industries.
Novius founder and CEO, Tomoko Fujino, can be made available for select Zoom-based video interviews
with media outlets in the United States or in-person and on-camera interviews with outlets in Japan.
Novius’ N-Vision 3D is available now with pricing and more information available at
https://novius.co.jp/en/. Novius is also seeking investors for its latest funding round.
About Novius: Novius, Inc. was founded in 2016 in Tokyo, Japan by Ms. Tomoko Fujino. Its mission is to
pioneer advanced AI solutions that rapidly transform 2D medical images into accurate 3D
representations, facilitating quicker and more comprehensive insights for healthcare professionals.
Committed to improving patient care, Novius strives to provide an accessible, high-fidelity 3D medical
imaging system, that can augment diagnostics, treatment decisions, and surgical interventions in real-
time. Novius’ goal in the medical field is real-time simulation by using information obtained from
angiography, CT, and MRI scans.

【Event】SOSV Health Tech Matchup – Feb 26-Mar 8, 2024

Happy new year 2024